Levin Capital Strategies L.P. boosted its position in CVS Health Corp (NYSE:CVS) by 6,358.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 523,796 shares of the pharmacy operator’s stock after buying an additional 515,686 shares during the period. Levin Capital Strategies L.P.’s holdings in CVS Health Corp were worth $41,333,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of the company. Integrated Wealth Management boosted its position in CVS Health Corp by 3.8% in the third quarter. Integrated Wealth Management now owns 1,348 shares of the pharmacy operator’s stock worth $120,000 after buying an additional 49 shares during the last quarter. Gemmer Asset Management LLC boosted its position in CVS Health Corp by 7.6% in the third quarter. Gemmer Asset Management LLC now owns 1,409 shares of the pharmacy operator’s stock worth $125,000 after buying an additional 100 shares during the last quarter. Klingman & Associates LLC boosted its position in CVS Health Corp by 27.5% in the third quarter. Klingman & Associates LLC now owns 1,625 shares of the pharmacy operator’s stock worth $145,000 after buying an additional 350 shares during the last quarter. Elgethun Capital Management bought a new position in CVS Health Corp during the fourth quarter worth $133,000. Finally, Arcadia Investment Management Corp MI boosted its position in CVS Health Corp by 5.9% in the third quarter. Arcadia Investment Management Corp MI now owns 1,700 shares of the pharmacy operator’s stock worth $151,000 after buying an additional 95 shares during the last quarter. 81.29% of the stock is owned by institutional investors and hedge funds.
CVS Health Corp (NYSE:CVS) traded down 0.19% during midday trading on Friday, hitting $79.28. 6,724,304 shares of the stock traded hands. The firm’s 50-day moving average is $78.91 and its 200-day moving average is $80.09. CVS Health Corp has a 52-week low of $69.30 and a 52-week high of $106.67. The company has a market cap of $84.12 billion, a price-to-earnings ratio of 16.15 and a beta of 0.85.
The firm also recently announced a quarterly dividend, which will be paid on Monday, May 1st. Stockholders of record on Friday, April 21st will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.52%. CVS Health Corp’s dividend payout ratio (DPR) is 40.65%.
COPYRIGHT VIOLATION NOTICE: This piece was posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://transcriptdaily.com/2017/04/22/cvs-health-corp-cvs-stake-raised-by-levin-capital-strategies-l-p.html.
A number of research analysts have weighed in on the stock. Leerink Swann set a $90.00 target price on shares of CVS Health Corp and gave the company a “buy” rating in a research note on Saturday, February 11th. Jefferies Group LLC set a $82.00 price target on shares of CVS Health Corp and gave the company a “hold” rating in a research note on Saturday, April 1st. Vetr upgraded shares of CVS Health Corp from a “hold” rating to a “buy” rating and set a $86.87 price target on the stock in a research note on Monday, January 23rd. Deutsche Bank AG restated a “hold” rating and set a $88.00 price target on shares of CVS Health Corp in a research note on Wednesday, February 8th. Finally, Atlantic Securities cut shares of CVS Health Corp from an “overweight” rating to a “neutral” rating and set a $84.00 price target on the stock. in a research note on Monday, February 6th. Seven equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. CVS Health Corp presently has a consensus rating of “Buy” and an average target price of $96.23.
In other CVS Health Corp news, EVP Jonathan C. Roberts sold 61,196 shares of the firm’s stock in a transaction on Thursday, February 16th. The stock was sold at an average price of $80.00, for a total value of $4,895,680.00. Following the transaction, the executive vice president now owns 89,955 shares in the company, valued at approximately $7,196,400. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Troyen A. Brennan sold 23,849 shares of the firm’s stock in a transaction on Tuesday, March 21st. The shares were sold at an average price of $78.73, for a total value of $1,877,631.77. Following the completion of the transaction, the executive vice president now owns 94,309 shares in the company, valued at approximately $7,424,947.57. The disclosure for this sale can be found here. Insiders have sold a total of 200,796 shares of company stock worth $16,101,642 in the last quarter. Insiders own 0.58% of the company’s stock.
CVS Health Corp Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
